Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis

被引：136
|
作者：
Dev, Kumlesh K. [1 ,2 ]
Mullershausen, Florian [3 ]
Mattes, Henri [2 ]
Kuhn, Rainer R. [2 ]
Bilbe, Graeme [2 ]
Hoyer, Daniel [2 ]
Mir, Anis [2 ]
机构：
[1] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland
[2] Nova Pharmaceut, Novartis Inst BioMed Res, Dept Neurosci, Basel, Switzerland
[3] Nova Pharmaceut, Novartis Inst BioMed Res, Dept G Prot Coupled Receptors, Basel, Switzerland
来源：
PHARMACOLOGY & THERAPEUTICS | 2008年 / 117卷 / 01期
关键词：
sphingosine-1-phosphate; SIP receptor; FTY720 (fingolimod); central nervous system; multiple sclerosis;
D O I：
10.1016/j.pharmthera.2007.08.005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Multiple sclerosis (MS) is an autoimmune, neurological disability with unknown etiology. The current therapies available for MS work by all immunomodulatory action, preventing T-cell- and macrophage-mediated destruction of brain-resident oligodendrocytes and axonal loss. Recently, FTY720 (fingolimod) was shown to significantly reduce relapse rates in MS patients and is currently in Phase III clinical trials. This drug attenuates trafficking of harmful T cells entering the brain by regulating sphingosine-1-phosphate (SIP) receptors. Here, we outline the direct roles that S I P receptors play in the central nervous system (CNS) and discuss additional modalities by which FTY720 may provide direct neuroprotection in MS. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码：77 / 93
页数：17
相关论文
共 50 条
  • [31] Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
    Kathrin Bail
    Quirin Notz
    Damiano M. Rovituso
    Andrea Schampel
    Marie Wunsch
    Tobias Koeniger
    Verena Schropp
    Richa Bharti
    Claus-Juergen Scholz
    Konrad U. Foerstner
    Christoph Kleinschnitz
    Stefanie Kuerten
    Journal of Neuroinflammation, 14
  • [32] What Is the Role of Sphingosine-1-Phosphate Receptors in Pain?
    Benarroch, Eduardo E.
    NEUROLOGY, 2021, 96 (11) : 525 - 528
  • [33] Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors
    Delgado, Antonio
    Martinez-Cartro, Miriam
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (03) : 242 - 264
  • [34] Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation
    Giordana, Maria Teresa
    Cavalla, Paola
    Uccelli, Antonio
    Laroni, Alice
    Bandini, Fabio
    Vercellino, Marco
    Mancardi, Gianluigi
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (08) : 1133 - 1137
  • [35] FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis
    Baumruker, Thomas
    Billich, Andreas
    Brinkmann, Volker
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (03) : 283 - 289
  • [36] Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
    Mehling, M.
    Lindberg, R.
    Raulf, F.
    Kuhle, J.
    Hess, C.
    Kappos, L.
    Brinkmann, V.
    NEUROLOGY, 2010, 75 (05) : 403 - 410
  • [37] FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
    Luessi, Felix
    Kraus, Stefan
    Trinschek, Bettina
    Lerch, Steffen
    Ploen, Robert
    Paterka, Magdalena
    Roberg, Torsten
    Poisa-Beiro, Laura
    Klotz, Luisa
    Wiendl, Heinz
    Bopp, Tobias
    Jonuleit, Helmut
    Jolivel, Valerie
    Zipp, Frauke
    Witsch, Esther
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (14) : 1811 - 1822
  • [38] Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
    Comi, G.
    O'Connor, P.
    Montalban, X.
    Antel, J.
    Radue, E-W
    Karlsson, G.
    Pohlmann, H.
    Aradhye, S.
    Kappos, L.
    MULTIPLE SCLEROSIS, 2010, 16 (02): : 197 - 207
  • [39] Sphingosine-1-Phosphate and Its Receptors: Structure, Signaling, and Influence
    Rosen, Hugh
    Stevens, Raymond C.
    Hanson, Michael
    Roberts, Edward
    Oldstone, Michael B. A.
    ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82, 2013, 82 : 637 - +
  • [40] Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems
    Healy, Luke M.
    Antel, Jack P.
    CURRENT DRUG TARGETS, 2016, 17 (16) : 1841 - 1850
12345